BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11092112)

  • 1. Unstable angina--a definitive role for statins in secondary prevention.
    Colquhoun D
    Int J Clin Pract; 2000; 54(6):383-9. PubMed ID: 11092112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid lowering agents. How important are they in secondary prevention of coronary heart disease?
    Colquhoun DM
    Aust Fam Physician; 2002 Jan; 31(1):25-6, 29-30. PubMed ID: 11840884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial.
    Den Hartog FR; Van Kalmthout PM; Van Loenhout TT; Schaafsma HJ; Rila H; Verheugt FW
    Int J Clin Pract; 2001 Jun; 55(5):300-4. PubMed ID: 11452676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina.
    Karatzis E; Lekakis J; Papamichael C; Andreadou I; Cimponeriu A; Aznaouridis K; Papaioannou TG; Protogerou A; Mavrikakis M
    Int J Cardiol; 2005 May; 101(1):65-70. PubMed ID: 15860385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U; Gathof BS
    Eur J Med Res; 2004 Jan; 9(1):1-17. PubMed ID: 14766335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trials and recent patterns in the use of statins.
    Wang TJ; Stafford RS; Ausiello JC; Chaisson CE
    Am Heart J; 2001 Jun; 141(6):957-63. PubMed ID: 11376310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins: new data in secondary prevention and diabetes. Pravastatin and simvastatin are the best-assessed statins.
    Prescrire Int; 2003 Aug; 12(66):143-8. PubMed ID: 12908497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of statin pleiotropism in acute coronary syndromes and stroke.
    Liao JK
    Int J Clin Pract Suppl; 2003 Mar; (134):51-7. PubMed ID: 12793598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical focus on statins.
    Auer J; Eber B
    Curr Opin Investig Drugs; 2001 Mar; 2(3):382-8. PubMed ID: 11575709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials?
    Ray KK; Cannon CP; Ganz P
    Am J Cardiol; 2006 Dec; 98(11A):18P-25P. PubMed ID: 17126675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early statin therapy in acute coronary syndromes.
    Kinlay S
    Minerva Cardioangiol; 2003 Oct; 51(5):577-84. PubMed ID: 14551525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
    Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
    J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pravastatin inflammation CRP evaluation (PRINCE): rationale and design.
    Albert MA; Staggers J; Chew P; Ridker PM;
    Am Heart J; 2001 Jun; 141(6):893-8. PubMed ID: 11376301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of statin use in patients with acute coronary syndromes and a serum low-density lipoproteinTsai TT; Nallamothu BK; Mukherjee D; Rubenfire M; Fang J; Chan P; Kline-Rogers E; Patel A; Armstrong DF; Eagle KA; Goldberg AD
    Am J Cardiol; 2005 Dec; 96(11):1491-3. PubMed ID: 16310427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of statins in acute coronary syndromes: managing the unmet need.
    Jackson G
    Int J Clin Pract; 2000 Sep; 54(7):445-9. PubMed ID: 11070569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial.
    Thompson PL; Meredith I; Amerena J; Campbell TJ; Sloman JG; Harris PJ;
    Am Heart J; 2004 Jul; 148(1):e2. PubMed ID: 15215811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.